Diclofenac Potassium instead of Sodium because...

Technology

IRT technology

Unique Immediate Release Technology

Potafast utilizes a patented Immediate Release Technology (IRT), which combines excipients and a specific ratio of diclofenac and bicarbonate. This unique formulation creates an optimal pH environment in the gastrointestinal tract, enhancing the solubility and absorption of diclofenac. As a result, Potafast delivers a faster and more consistent onset of action compared to conventional formulations.

Advantages of this technology:

– Fast onset of action

– Consistent absorption.

– Enhanced efficacy and patient compliance.

Potafast

We are committed to delivering trusted, FDA-approved pain relief with our patented technology, setting a new standard in the treatment of migraine and other pain conditions.